DocGo Statistics
Total Valuation
DocGo has a market cap or net worth of $105.63 million. The enterprise value is $61.92 million.
Important Dates
The next confirmed earnings date is Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DocGo has 97.81 million shares outstanding. The number of shares has decreased by -6.15% in one year.
| Current Share Class | 97.81M |
| Shares Outstanding | 97.81M |
| Shares Change (YoY) | -6.15% |
| Shares Change (QoQ) | -2.62% |
| Owned by Insiders (%) | 7.33% |
| Owned by Institutions (%) | 48.55% |
| Float | 85.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | 0.35 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | 1.27 |
| P/OCF Ratio | 1.21 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.74 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.36 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.73 |
| Interest Coverage | -9.86 |
Financial Efficiency
Return on equity (ROE) is -9.07% and return on invested capital (ROIC) is -5.01%.
| Return on Equity (ROE) | -9.07% |
| Return on Assets (ROA) | -4.02% |
| Return on Invested Capital (ROIC) | -5.01% |
| Return on Capital Employed (ROCE) | -9.35% |
| Revenue Per Employee | $98,926 |
| Profits Per Employee | -$4,158 |
| Employee Count | 4,407 |
| Asset Turnover | 0.97 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.05% in the last 52 weeks. The beta is 0.93, so DocGo's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -68.05% |
| 50-Day Moving Average | 1.35 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 41.05 |
| Average Volume (20 Days) | 4,246,605 |
Short Selling Information
The latest short interest is 4.25 million, so 4.34% of the outstanding shares have been sold short.
| Short Interest | 4.25M |
| Short Previous Month | 4.55M |
| Short % of Shares Out | 4.34% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 5.74 |
Income Statement
In the last 12 months, DocGo had revenue of $435.97 million and -$18.33 million in losses. Loss per share was -$0.19.
| Revenue | 435.97M |
| Gross Profit | 146.69M |
| Operating Income | -28.81M |
| Pretax Income | -30.26M |
| Net Income | -18.33M |
| EBITDA | -13.57M |
| EBIT | -28.81M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $104.16 million in cash and $60.45 million in debt, giving a net cash position of $43.71 million or $0.45 per share.
| Cash & Cash Equivalents | 104.16M |
| Total Debt | 60.45M |
| Net Cash | 43.71M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 287.73M |
| Book Value Per Share | 3.04 |
| Working Capital | 136.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $87.35 million and capital expenditures -$4.02 million, giving a free cash flow of $83.33 million.
| Operating Cash Flow | 87.35M |
| Capital Expenditures | -4.02M |
| Free Cash Flow | 83.33M |
| FCF Per Share | $0.85 |
Full Cash Flow StatementMargins
Gross margin is 33.65%, with operating and profit margins of -6.61% and -4.20%.
| Gross Margin | 33.65% |
| Operating Margin | -6.61% |
| Pretax Margin | -6.94% |
| Profit Margin | -4.20% |
| EBITDA Margin | -3.11% |
| EBIT Margin | -6.61% |
| FCF Margin | 19.11% |
Dividends & Yields
DocGo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.15% |
| Shareholder Yield | 6.15% |
| Earnings Yield | -17.35% |
| FCF Yield | 78.89% |
Analyst Forecast
The average price target for DocGo is $3.37, which is 212.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.37 |
| Price Target Difference | 212.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DocGo has an Altman Z-Score of 2.82 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 4 |
